Daniel Silverman, MD
Nuclear Medicine · Los Angeles, CANPI 1295761880
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,960 of the $7,621 with a category attached, or 91.3%. Eisai Inc. accounts for 95.2% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2020 at $7,172 and has fallen 99.8% since, to $14 in 2025. Among nuclear medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 25 payments — averaging $304.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$7K
- Novartis$316
- Life Molecular Imaging Ltd$50
Across 134 payments — averaging $1051.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eisai Inc.$141K
What the payments were for
- Consulting fees$6,96091%
- Food & beverage$6619%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 7 | $7,255 |
| Novartis | 17 | $316 |
| Life Molecular Imaging Ltd | 1 | $50 |
How this compares
$7,621 in reported general payments places this provider in the 90th percentile of 110 nuclear medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nuclear medicine in Los Angeles
- Hossein JadvarLos Angeles$294K
- Johannes CzerninLos Angeles$24K
- Gholam BerenjiLos Angeles$15K
- Shahram BonyadlouLos Angeles$12K
- Patrick CollettiLos Angeles$578
- Do KimLos Angeles$508
- David WinsorLos Angeles$136
- Shadfar BahriLos Angeles$80
- Louise ThomsonLos Angeles$31
- Michael DaeSan Francisco$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.